CTLA4 and breast carcinoma: Reports indicate that breast cancer susceptibility and prediction can be influenced by the polymorphism of cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene, which encodes a classic molecule offering a co-inhibitory signal to T cell activation [19].